Navigation Links
Genencor promotes biobased economy to address challenges of fast-growing world population
Date:10/5/2011

PALO ALTO, Calif. Oct. 5, 2011 Today at the first-annual California Industrial Biotechnology Conference, Genencor called for the collaboration of industry, science and policy stakeholders to help solve the challenges of a growing world population through accelerating a biobased economy. A biobased economy is driven by the use of renewable sources for energy, fuels and the production of chemicals and materials.

"The global population is expected to increase to 9 billion by 2050, and we are already experiencing challenges in meeting the needs for food, energy and protection," said Genencor CEO Tjerk de Ruiter. "Working together to power industrial biotechnology solutions and educate others about them can help boost the economy, reduce our dependence on fossil fuels, create a healthier environment and decrease water and energy consumption."

Genencor recommended four key components necessary for creating a biobased economy:

  • Cultivating a steady supply of renewable feedstock;

  • Developing infrastructure (from farm to factory);

  • Building sustainable biorefineries; and

  • Developing and securing responsive distribution channels.

De Ruiter said the best collaboration to help develop the foundation for a biobased economy needs to consist of: public and private partnerships; governmental policies and industry incentives; a regulatory framework that doesn't stifle entrepreneurial innovation; and public education. Genencor has been seeking new partnerships to address the needs of a growing population through its open innovative program called GNext, as well as making significant progress in developing cost-effective enzyme technologies that are helping to solve the world's sustainability issues.

For example, Genencor's newest enzyme technology, Accellerase TRIO, will help the United States reduce its dependence on a petroleum-based economy by allowing advanced biofuels producers to cost-effectively manufacture cellulosic ethanol from a range of renewable, nonfood feedstocks. Advanced biofuels have the potential to reduce greenhouse gas emissions up to 86 percent over gasoline.

Genencor's BioIsoprene platform is another biobased alternative for the rapidly growing automotive and transportation industries. A partnership between Genencor and The Goodyear Tire Company, BioIsoprene platform is an alternative to petroleum-derived isoprene, a key chemical in synthetic rubber. The technology also has a vast potential beyond tires, including becoming key ingredients in rubber products and adhesives.

"Indeed we are making progress. The challenge ahead of us is to work as a collective group to take discoveries from pilot projects to commercialization faster," De Ruiter said. "Working toward establishing a biobased economy will help us be better prepared to address society's biggest challenges."


'/>"/>

Contact: Chris Nguyen
chris.nguyen@danisco.com
650-276-9189
Environics
Source:Eurekalert

Related biology news :

1. Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes
2. Advancement in tissue engineering promotes oral wound healing
3. Prairie dog research promotes caring, conservation
4. Protein that promotes cancer cell growth identified
5. New Web site promotes interoperable newborn screening data
6. Newly identified growth factor promotes stem cell growth, regeneration
7. Rhodopsin phototrophy promotes bacterial survival
8. 2 dogs 2,000 miles trek promotes dog DNA for cancer research
9. Engineering textbook promotes social justice
10. CSHL team shows how loss of key protein promotes aggressive form of leukemia
11. Sewage overflow promotes spread of West Nile virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
(Date:1/11/2017)... Johnson, co-founder of Visikol Inc. a company originally funded with an ... the elite "Forbes 30 Under 30" list in the Science category. ... fields nationwide to be recognized as a leader in business and ... ... PhD candidate at Rutgers University. Visikol , ...
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at this ... leader in connected health and biometric measurement devices and services, will be ... On display in A&D Medical,s special CES Exhibit Suite , ... ongoing expansion of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, which ... it has submitted a 510(k) to the FDA, requesting clearance of the MyoCycle ... electrical stimulation (FES) technology. , The submission marks a major milestone for ...
(Date:1/18/2017)... ... January 18, 2017 , ... DrugDev ... Summit for Clinical Ops Executives (Hyatt Regency Miami, January 24-26). DrugDev will join ... clinical research issues such as trial performance metrics, patient enrollment diversity, protocol optimization, ...
(Date:1/18/2017)... CA (PRWEB) , ... January 18, 2017 , ... ... report the publishing of the latest paper by its Science Editor, Dr. Elisabeth ... (Nederlands Tijdschrift voor Medische Microbiologie). Dr. Bik joined uBiome in October 2016 from ...
(Date:1/18/2017)... Jan. 18, 2017 Shareholder rights law firm ... whether the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... connection with the proposed sale of the Company to ... that develops small molecules for the acute treatment of ... it had signed a definitive merger agreement with Eli ...
Breaking Biology Technology: